Hybio Pharmaceutical (300199) — Capital Reinvestment Ratio
Latest as of September 2025:
0.81x
Hybio Pharmaceutical (300199) has a Capital Reinvestment Ratio of 0.81x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥117.78 Million) in capital expenditures (CN¥95.60 Million). See 300199 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.81x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥117.78 Million
CNY
Capital Expenditures
CN¥95.60 Million
CNY
Data as of
Sep 2025
Most recent filing
Hybio Pharmaceutical Capital Reinvestment Ratio (2007–2024)
This chart tracks Hybio Pharmaceutical's Capital Reinvestment Ratio across 17 annual periods.
Annual Capital Reinvestment Ratio for Hybio Pharmaceutical (2007–2024)
Year-by-year Capital Reinvestment Ratio for Hybio Pharmaceutical from 2007 to 2024. For live market cap and broader valuation context, see Hybio Pharmaceutical (300199) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.70x | CN¥164.71 Million | CN¥115.84 Million | ▼ -94.1% |
| 2022 | 12.01x | CN¥15.81 Million | CN¥189.85 Million | ▲ +846.5% |
| 2021 | 1.27x | CN¥156.83 Million | CN¥199.00 Million | ▼ -75.0% |
| 2020 | 5.08x | CN¥47.99 Million | CN¥243.66 Million | ▼ -6.8% |
| 2019 | 5.45x | CN¥104.64 Million | CN¥570.15 Million | ▼ -29.9% |
| 2018 | 7.78x | CN¥47.00 Million | CN¥365.58 Million | ▲ +651.8% |
| 2017 | 1.03x | CN¥213.74 Million | CN¥221.14 Million | ▲ +164.3% |
| 2016 | 0.39x | CN¥296.41 Million | CN¥116.05 Million | ▼ -84.9% |
| 2015 | 2.59x | CN¥138.84 Million | CN¥358.98 Million | ▲ +365.8% |
| 2014 | 0.56x | CN¥153.43 Million | CN¥85.16 Million | ▼ -71.9% |
| 2013 | 1.97x | CN¥153.48 Million | CN¥302.85 Million | ▼ -22.3% |
| 2012 | 2.54x | CN¥87.19 Million | CN¥221.38 Million | ▲ +135.1% |
| 2011 | 1.08x | CN¥72.48 Million | CN¥78.27 Million | ▲ +158.8% |
| 2010 | 0.42x | CN¥54.69 Million | CN¥22.83 Million | ▲ +21.0% |
| 2009 | 0.34x | CN¥26.11 Million | CN¥9.01 Million | ▼ -73.8% |
| 2008 | 1.32x | CN¥45.75 Million | CN¥60.28 Million | ▲ +1219.7% |
| 2007 | 0.10x | CN¥49.04 Million | CN¥4.90 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow